Design of Novel Imidazole Derivatives as Potential Non-nucleoside Reverse Transcriptase Inhibitors using Molecular Docking and Dynamics Strategies
The results of the current study demonstrate the robustness of our in silico drug design strategy that can be used for the discovery of novel HIV-1-RT inhibitors.
Authors
- Swastika Ganguly (ORCID: https://orcid.org/0000-0001-5042-0773)
- Pran Kishore Deb (ORCID: https://orcid.org/0000-0002-8650-2874)
- Manik Ghosh (ORCID: https://orcid.org/0000-0003-2846-2971)
- Priyanka Chandra (ORCID: https://orcid.org/0000-0002-7789-3965)
Institutions
- Birla Institute of Technology, Mesra (IN)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2024-10-02
- DOI
- https://doi.org/10.2174/0113816128322984240725055333
- Citations
- 5
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.95